Healthcare Global Enterprises Ltd. (HCG)
BSE
Closed
Aug 24, 2026
Day's Range
710.0052 wk Range
513.40Overview - HCG - Healthcare Global Enterprises Ltd.
Key Statistics
Valuation
Enterprise Value
121.27B
P/E (Trailing)
‪473.98‬
P/E (Forward)
‪46.58‬
PEG Ratio
‪2.75‬
Price / Sales (TTM)
‪4.12‬
Price / Book
‪7.87‬
EV / EBITDA
‪24.49‬
Profitability
Gross Margin
‪51.50%‬
Profit Margin
‪0.86%‬
Operating Margin
‪7.45%‬
Return on Assets
‪0.35%‬
Return on Equity
‪0.97%‬
Ownership
Shares Outstanding
149.30M
Float
59.49M
Held by Insiders
‪70.63%‬
Held by Institutions
‪19.03%‬
Price stats
Beta
‪-0.03‬
50-Day Avg
‪661.73‬
200-Day Avg
‪635.01‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪₹ 806.80‬Market Cap - HCG - Healthcare Global Enterprises Ltd.
Peers - HCG - Healthcare Global Enterprises Ltd.
Peer Comparison
Compared with companies in Medical Care Facilities listed on BSE.
Profile Summary - HCG - Healthcare Global Enterprises Ltd.
About
Healthcare Global Enterprises Ltd. is a leading healthcare provider primarily focused on oncology and related healthcare services. Established in 1989, the company has carved a niche in delivering specialized cancer treatment and diagnostics across multiple locations in India. Healthcare Global Enterprises Ltd.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
